OR for developing DLB or AD relative to APOEε2 and APOEε4 alleles
| DLB vs CTR | AD vs CTR | |
|---|---|---|
| No. of APOE alleles | ||
| 1 or 2 APOE ε2 alleles | ||
| OR | 0.4 | 0.5 |
| CI | 0.2 to 0.7 | 0.4 to 0.7 |
| p Value | 0.002 | <0.0005 |
| 1 APOE ε4 allele | ||
| OR | 3.0 | 4.3 |
| CI | 2.1 to 4.3 | 3.3 to 5.7 |
| p Value | <0.0005 | <0.0005 |
| 2 APOE ε4 alleles | ||
| OR | 6.0 | 19.3 |
| CI | 2.8 to 13.1 | 10.8 to 34.2 |
| p Value | <0.0005 | <0.0005 |
AD, Alzheimer's disease; CTR, healthy controls; DLB, dementia with Lewy bodies.